Cargando…

Estrogen receptor alpha drives mTORC1 inhibitor-induced feedback activation of PI3K/AKT in ER+ breast cancer

The mTORC1 inhibitor RAD001 (everolimus) is approved for treatment of recurrent/metastatic estrogen receptor (ER)-positive breast cancer in combination with the aromatase inhibitor (AI) exemestane. The benefits of A) continued anti-estrogen therapy for anti-estrogen-resistant disease in the context...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Wei, Schwartz, Gary N., Marotti, Jonathan D., Chen, Vivian, Traphagen, Nicole A., Gui, Jiang, Miller, Todd W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823630/ https://www.ncbi.nlm.nih.gov/pubmed/29507656 http://dx.doi.org/10.18632/oncotarget.24256

Ejemplares similares

PI3K/Akt promotes feedforward mTORC2 activation through IKKα
por: Dan, Han C., et al.
Publicado: (2016)

mTORC1 directly phosphorylates and activates ERα upon estrogen stimulation
por: Alayev, A, et al.
Publicado: (2015)

Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development
por: Liu, Pin, et al.
Publicado: (2017)

AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis
por: Mi, Wenting, et al.
Publicado: (2015)

High estrogen receptor alpha activation confers resistance to estrogen deprivation and is required for therapeutic response to estrogen in breast cancer
por: Traphagen, Nicole A., et al.
Publicado: (2021)

Catabolic pathways regulated by mTORC1 are pivotal for survival and growth of cancer cells expressing mutant Ras
por: Sung, Suhyun, et al.
Publicado: (2015)

Rapamycin-induced miR-21 promotes mitochondrial homeostasis and adaptation in mTORC1 activated cells
por: Lam, Hilaire C., et al.
Publicado: (2017)

mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition
por: Xue, Gongda, et al.
Publicado: (2017)

Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma
por: Carita, Guillaume, et al.
Publicado: (2016)

mTORC1/2 inhibition re-sensitizes platinum-resistant ovarian cancer by disrupting selective translation of DNA damage and survival mRNAs
por: David-West, Gizelka, et al.
Publicado: (2018)

RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes
por: Weinberg, Mark A.
Publicado: (2016)

Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity
por: Takizawa, Itsuhiro, et al.
Publicado: (2014)

Livers with Constitutive mTORC1 Activity Resist Steatosis Independent of Feedback Suppression of Akt
por: Kenerson, Heidi L., et al.
Publicado: (2015)

A new class of small molecule estrogen receptor-alpha antagonists that overcome anti-estrogen resistance
por: Ma, Yongxian, et al.
Publicado: (2015)

Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A
por: Xu, Bi-Hong, et al.
Publicado: (2015)

Modulation of estrogen related receptor alpha activity by the kinesin KIF17
por: Seneviratne, AM Pramodh Bandara, et al.
Publicado: (2017)

Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancer
por: Hosford, Sarah R., et al.
Publicado: (2019)

TFEB-mTORC1 feedback loop in metabolism and cancer
por: Di Malta, Chiara, et al.
Publicado: (2017)

mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016)

Sensing of RNA stress by mTORC1 drives autoinflammation
por: Lee-Kirsch, Min Ae
Publicado: (2022)

Dual function of the PI3K-Akt-mTORC1 axis in myelination of the peripheral nervous system
por: Figlia, Gianluca, et al.
Publicado: (2017)

Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?
por: Prossomariti, Anna, et al.
Publicado: (2020)

Prolonged deprivation of arginine or leucine induces PI3K/Akt-dependent reactivation of mTORC1
por: Buel, Gwen R., et al.
Publicado: (2022)

mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis
por: Martinez Calejman, C., et al.
Publicado: (2020)

Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
por: Tang, Haiyang, et al.
Publicado: (2018)

PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphoma
por: Pongas, Georgios N., et al.
Publicado: (2017)

High glutamine suppresses osteogenesis through mTORC1-mediated inhibition of the mTORC2/AKT-473/RUNX2 axis
por: Gayatri, Meher Bolisetti, et al.
Publicado: (2022)

Macropinocytosis drives T cell growth by sustaining the activation of mTORC1
por: Charpentier, John C., et al.
Publicado: (2020)

Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion
por: Chen, Long, et al.
Publicado: (2015)

The metabolic waste ammonium regulates mTORC2 and mTORC1 signaling
por: Merhi, Ahmad, et al.
Publicado: (2017)

mTORC1 is necessary but mTORC2 and GSK3β are inhibitory for AKT3-induced axon regeneration in the central nervous system
por: Miao, Linqing, et al.
Publicado: (2016)

Vertical inhibition of the mTORC1/mTORC2/PI3K pathway shows synergistic effects against melanoma in vitro and in vivo
por: Werzowa, Johannes, et al.
Publicado: (2010)

mTORC1 inhibitor rapamycin and ER stressor tunicamycin induce differential patterns of ER-mitochondria coupling
por: Bravo-Sagua, Roberto, et al.
Publicado: (2016)

Uncoupling TORC2 from AGC kinases inhibits tumour growth
por: Cameron, Angus J.M., et al.
Publicado: (2017)

GILZ inhibits the mTORC2/AKT pathway in BCR-ABL(+) cells
por: Joha, S, et al.
Publicado: (2012)

Dynamic Adipocyte Phosphoproteome Reveals that Akt Directly Regulates mTORC2
por: Humphrey, Sean J., et al.
Publicado: (2013)

Role of AKT/mTORC1 pathway in pancreatic β-cell proliferation.
por: Balcazar Morales, Norman, et al.
Publicado: (2012)

SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt
por: Meng, Haitao, et al.
Publicado: (2013)

ER-lysosome contacts enable cholesterol sensing by mTORC1 and drive aberrant growth signaling in Niemann-Pick type C
por: Lim, Chun-Yan, et al.
Publicado: (2019)

mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation
por: Ding, Xiaolei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8g0dett8qma0vb8q3dd9dtpdjg